The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Temple University
- Study ID
- NCT05499507
- Status
- Recruiting
Conditions
- Hypertension
- Obesity
- Pregnancy Related
- Racism
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- COH — BEHAVIORALIncorporates two, evidence-based individual-level interventions (home blood pressure telemonitoring coupled with the interactive obesity treatment approach, that includes nutrition and physical activity text messages with tailored feedback) and an institutional-level intervention (anti-racism training of providers and staff along with patient feedback to inform respectful care).
- COH+ — BEHAVIORALIncludes all components of COH plus interpersonal support for Black women by Black women (community doula care, mental health services, and lactation support).
Study Details
The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.
Key Dates
- Start date
- Jan 24, 2023
- Status verified
- Dec 2025
- Primary completion
- Jul 15, 2027
- Completion
- Dec 10, 2028
Study Design
- Enrollment
- 432 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Change of Heart (COH)Incorporates two, evidence-based individual-level interventions (home blood pressure telemonitoring coupled with the interactive obesity treatment approach, that includes nutrition and physical activity text messages with tailored feedback) and an institutional-level intervention (anti-racism training of providers and staff along with patient feedback to inform respectful care).
- Experimental: Change of Heart Plus (COH+)Includes all components of COH plus the addition of interpersonal support for Black women by Black women (community doula care, mental health services, and lactation support).
Primary Outcome Measure
Change in blood pressure at 6-weeks postpartum. [ Time Frame: At baseline and 6-weeks postpartum ]
Central Contacts
- Sharon J Herring, MD, MPH2157072234
- Christine Santoro, CPM, MA
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Temple University/Temple Health | Philadelphia | Pennsylvania | 19140 |
Find similar trials in Philadelphia, PA
By research site
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Early Antenatal Support for Iron Deficiency AnemiaPHASE4 · Recruiting · Thomas Jefferson University · Philadelphia, Pennsylvania
- Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum PeriodRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania